Circ_0000972通过向miR-96-5p/PFN1抑制肝细胞癌细胞干细胞
Jintian Tang1, Runjuan Tang2, Feng Xue3
1Department of Hepatopancreatobiliary, Cancer Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou East Street, Urumqi, 830000, Xinjiang, China. doctor163email@163.com.
Biochemical genetics
|December 2, 2024
概括
循环RNAcirc_0000972通过海绵化miR-96-5p来抑制肝细胞癌的进展,以调节PFN1. 这一发现为肝细胞癌癌干细胞提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 循环RNAs (circRNAs) 在癌症干细胞 (CSC) 进展中起着关键作用,影响瘤的开始和发展.
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战,肝细胞癌 (CSC) 导致其复发和对治疗的抗性.
研究的目的:
- 研究circ_0000972在肝细胞癌癌干细胞 (HCC CSCs) 中的功能作用和潜在的分子机制.
- 在HCC进展的背景下,阐明circ_0000972,miR-96-5p和profilin 1 (PFN1) 之间的相互作用.
主要方法:
- 定量逆转录聚合酶链反应 (RT-qPCR) 用于评估基因表达水平.
- 在体内异种移植模型和体内测试 (殖民地形成,球体形成) 以评估功能影响.
- 生物信息学分析,双露西法酶记者测定和救援实验以确定分子相互作用.
主要成果:
- 在HCC组织和细胞中,Circ_0000972和PFN1的下调,而miR-96-5p的上调.
- 过度表达circ_0000972抑制了HCC CSC干,殖民地形成,球体形成和上皮-介质细胞过渡 (EMT),并在体内抑制了瘤生长.
- Circ_0000972 作为 miR-96-5p 的分子海绵,从而增加 PFN1 的表达,并抑制 HCC 的致癌过程.
结论:
- 通过调节miR-96-5p/PFN1轴,Circ_0000972作为HCC中的抗瘤因子起作用.
- 向circ_0000972可能是对抗肝细胞癌,特别是其干细胞驱动方面的新疗法策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


